Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$80.52 - $93.75 $5,153 - $6,000
64 Added 2.74%
2,400 $203,000
Q1 2022

May 09, 2022

BUY
$80.11 - $90.62 $187,136 - $211,688
2,336 New
2,336 $205,000
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $226,108 - $250,024
-2,837 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$81.78 - $95.14 $33,775 - $39,292
413 Added 17.04%
2,837 $232,000
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $206,621 - $228,219
2,424 New
2,424 $221,000
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $222,360 - $262,225
-2,663 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $207,900 - $251,467
2,663 New
2,663 $251,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $280,097 - $310,310
-3,410 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$80.93 - $91.1 $275,971 - $310,651
3,410 New
3,410 $298,000
Q2 2018

Aug 10, 2018

SELL
$64.91 - $73.36 $221,927 - $250,817
-3,419 Closed
0 $0
Q1 2018

Apr 25, 2018

BUY
$70.39 - $84.15 $7,461 - $8,919
106 Added 3.2%
3,419 $276,000
Q4 2017

Feb 06, 2018

BUY
$72.33 - $77.64 $22,928 - $24,611
317 Added 10.58%
3,313 $278,000
Q3 2017

Nov 08, 2017

BUY
$74.14 - $77.27 $222,123 - $231,500
2,996
2,996 $257,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.